Please login to the form below

Varuby

This page shows the latest Varuby news and features for those working in and with pharma, biotech and healthcare.

J&J gets CHMP backing for broader Darzalex use

Tesaro picked up a positive opinion for Varuby (rolapitant), an oral substance P/neurokinin-1 (NK-1) receptor antagonist for treating chemotherapy-induced nausea and vomiting, and Shire got the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Senior Medical Writer: Salary TBC

Associate Director: £75, 000-90, 000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Senior Account Director development role to Business Director, H...: Excellent package

Medical Writer: Salary TBC

Account Director: Competitive Salary Offered

Senior Account Manager: Competitive Salary Offered

Business Director: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director, Medical Education: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Director – Healthcare PR – Global Agency: Salary TBC

Global Business Development Director – Health Education: excellent commission

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Account Manager / Account Director: Competative

Subscribe to our email news alerts

PMHub

Add my company

Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt: ...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....